Fox Chase Cancer Center Physicians and Scientists Present Research at the ASTRO 2024 Annual Meeting

ASTRO Presentations
Fox Chase Cancer Center physicians and scientists will participate in the presentation and discussion of nine research projects at the American Society for Radiation Oncology (ASTRO) 2024 Annual Meeting, which is being held in Washington, D.C., from September 29 through October 2.

PHILADELPHIA (September 30, 2024) — Fox Chase Cancer Center physicians and scientists will participate in the presentation and discussion of nine research projects at the American Society for Radiation Oncology (ASTRO) 2024 Annual Meeting, which is being held in Washington, D.C., from September 29 through October 2.

Sunday, September 29

2094: Assessing the Safety and Efficacy of a Hypofractionated Regimen in the Treatment of Early-Stage Non-Small Cell Lung Cancer Patients with Central or Ultracentral Tumors: Maryanne Lubas, DO; Fox Chase Cancer Center; PQA 01 – PQA 01 Lung Cancer/Thoracic Malignancies and Diversity, Equity and Inclusion in Healthcare Poster Q&A; Sunday, September 29; 2:45 PM – 4:15 PM ET; Location: Hall C.

140: Incidence of Cervical Cancer Subtypes in Relation to HPV Vaccination Uptake in the U.S.: Peter Lee, MD, PhD, Fox Chase Cancer Center; SS 07 - GYN 3 Quest for Prognostic and Predictive Biomarkers in Gynecological Malignancies; Sunday, September 29, 3:25 PM – 3:35 PM ET; Location: Room 207 B.

2272: Initial Experience With a CBCT-Based Adaptive Radiotherapy System: Ahmed Eldib, PhD; Fox Chase Cancer Center; PQA 02 – PQA 02 Physics Poster Q&A; Sunday, September 29; 4:45 PM – 6:00 PM ET; Location: Hall C.

Monday, September 30

3540: Impact of Total Dose and Treatment Modality on Survival in Inoperable Endometrial Cancer in the National Cancer Database: Alexander Lukez, MD; Fox Chase Cancer Center; PQA 03 – PQA 03 Gynecological Cancer, Pediatric Cancer, and Professional Development Poster; Monday, September 30; 8 AM – 9 AM ET; Location: Hall C.

2513: Adaptive Radiation Therapy (ART) of Spinal Metastases: Motion Between a Rock and a Hard Place: Robert Freeman, MD; Fox Chase Cancer Center; PQA 04 – PQA 04 Palliative Care and Central Nervous System Poster Q&A; Monday, September 30; 10:45 AM – 12 PM ET; Location: Hall C.

2704: Treatment Implications of Low Compliance With Endocrine Therapy for Older Women With Early-Stage Breast Cancer: Maryanne Lubas, DO; Fox Chase Cancer Center; PQA 05 – PQA 05 Breast Cancer and Nonmalignant Disease Poster Q&A; Monday, September 30; 3 PM – 4 PM ET; Location: Hall C.

1024: CT-Guided Online Adaptive Stereotactic Body Radiation Therapy for Liver Tumors: Alexander Lukez, MD; Fox Chase Cancer Center; QP 05 – Phy 8: Adaptive Therapy; Monday, September 30; 5 PM – 5:10 PM ET; Location: Room 147.

2921: Investigating Tumor Response and Efficacy of 5-Aminolevulinic Acid-Mediated Radiodynamic Therapy: Utilizing Photon Irradiation, Activation of Photosensitizer and Catalytic Effects: Dae-Myoung    Yang, PhD; Fox Chase Cancer Center; PQA 06 – PQA 06 Biology and Patient Reported Outcomes/QoL/Survivorship Poster Q&A; Monday, September 30; 5 PM – 6 PM ET; Location: Hall C.

1022: ACRIN 6685 PET-CT Threshold to Reinterpret Pre-Treatment Head and Neck Cancer (HNC) Imaging? Stage Migration and Treatment Outcomes: Nuverah Mohsin, MD, BS; Fox Chase Cancer Center;     QP 04 – H&N 4 Pitching Clinically-Focused Research to Improve Outcomes and Prognostication; Monday, September 30; 5:40 PM – 5:50 PM ET; Location: Room 152. 

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text